Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease.
Shang-Chin HuangHau-Jyun SuJia-Horng KaoTai-Chung TsengHung-Chih YangTung-Hung SuPei-Jer ChenChun-Jen LiuPublished in: Gut and liver (2021)
The novel diagnostic criteria for MAFLD include an additional 38.9% of patients with hepatic steatosis and can better help identify those with a high degree of disease severity for early intervention than can the previous NAFLD criteria.